Searchable abstracts of presentations at key conferences in endocrinology

ea0032p1091 | Thyroid cancer | ECE2013

Treating refractory thyroid cancer in the era of multitarget tyrosine kinase inhibitors

Mathiopoulou Lemonia , Boudina Maria , Chrisoulidou Alexandra , Mandanas Stylianos , Margaritidou Efterpi , Georgopoulos Konstantinos , Pazaitou-Panayiotou Kalliopi

Introduction: Tyrosine kinase inhibitors (sorafenib and sunitinib) have been used in treating refractory cases of thyroid cancer. The aim of our present study was to assess the efficacy of these agents in patients with refractory and progressive thyroid cancer, regarding patients’ quality of life, adverse events and response ratesPatients and methods: We retrospectively analyzed data of adult patients with differentiated and medullary thyroid cancer...

ea0020oc3.1 | Reproduction/Stress/Endocrine Disruptors | ECE2009

Gapapentin for the treatment of hot flushes in women with natural or tamoxifen-induced menopause: a systematic review and a meta-analysis

Toulis Konstantinos , Tzellos Thrasivoulos , Kouvelas Dimitrios , Goulis Dimitrios , Tarlatzis Basil , Papadimas Ioannis

Context: Evidence suggests that gabapentin, a γ-aminobutyric acid analogue, is effective in the treatment of hot flushes in women with natural or tamoxifen-induced menopause.Objective and design: To investigate the efficacy and tolerability of gabapentin for the treatment of menopausal hot flushes, a systematic review of all pertinent trials and a meta-analysis of those that were randomized placebo-controlled (RCT) were performed.<p class="abste...

ea0020p304 | Clinical case reports and clinical reports | ECE2009

Double primary ovarian malignancies in a patient with bipolar disease complicating Swyer syndrome

Zapanti Evangelia , Giakioumi Athanasia , Terzidis Konstantinos , Thomakos Nikolaos , Rodolakis Alexandros , Grigori P , Alevizaki Maria

Background: Swyer syndrome is a type of pure gonadal dysgenesis 46 XY caryotype in phenotypically female patients. A rare case of Swyer syndrome complicated by dysgerminoma and Retiform Sertoli-Leydig cell’s tumor is reported.Case presentation: A 20-year-old phenotypically female patient presented to our department with primary amenorrhea. She was 1.68 m and weighed 82 kg (BMI 28). She presented with minimal breast development, sparse axillary and p...

ea0020p634 | Reproduction | ECE2009

A systematic review and a meta-analysis on adiponectin levels in women with polycystic ovary syndrome

Toulis Konstantinos , Goulis Dimitrios , Farmakiotis Dimitrios , Katsikis Ilias , Georgopoulos Neoklis , Tarlatzis Basil , Papadimas Ioannis , Panidis Dimitrios

Background: Conflicting results regarding adiponectin levels in women with polycystic ovary syndrome (PCOS) have been reported. To evaluate adiponectin levels in PCOS, a systematic review of all studies comparing adiponectin levels in women with PCOS to healthy controls and a meta-analysis of those involving women with similar Body Mass Index (BMI) were performed. Influence of possible effect modifiers, such as insulin resistance (IR) and testosterone, was investigated. Influe...

ea0016p94 | Bone and calcium | ECE2008

Scintigraphic, biochemical and clinical response to zoledronic acid treatment in patients with Paget's disease of bone

Avramidis Avraam , Polyzos Stergios , Moralidis Efstratios , Arsos Georgios , Efstathiadou Zoe , Karakatsanis Konstantinos , Grollios Georgios , Kita Marina

Introduction: Bisphosponates have long been used with success in the treatment of Paget’s disease of bone (PDB). The aim of this study was to evaluate the early (up to three months) and late (at twelve months) scintigraphic, biochemical and clinical response to a single intravenous infusion of zoledronic acid (ZOL) in patients with PDB serially assessed for one year.Materials and methods: Nine patients with 30 bone lesions due to PDB were prospectiv...

ea0073aep90 | Calcium and Bone | ECE2021

Fibrosis 4 score is associated with bone density measures in postmenopausal women

Armeni Eleni , Augoulea Areti , Paschou Stavroula , Palaiologou Anastasia , Kaparos Georgios , Panoulis Konstantinos , Lambrinoudaki Irene

IntroductionThe routine assessment of postmenopausal women involves screening for cardiometabolic risk factors and bone health. Evaluation of the liver function is not commonly performed, even though this could be easily performed with the use of indirect markers, such as the Fibrosis 4 score. Recent evidence supports an association between liver cirrhosis and bone turnover, affecting both the trabecular and the cortical bone. Therefore, we aimed to expl...

ea0073aep188 | Diabetes, Obesity, Metabolism and Nutrition | ECE2021

Feasibility study of IoT telemonitoring for elderly patients with type 2 diabetes mellitus: Results of the Greek pilot of the ACTIVAGE multicenter randomised control trial

Dafoulas George , Karaberi Christina , Segkouli Sofia , Dimakopoulos George , Votis Konstantinos , Tzovaras Dimitrios , Bargiota Alexandra

IntroductionThe aim of the present feasibility study was to examine the impact of an Internet of Things (IoT) telemonitoring program, for elderly patients with type 2 diabetes mellitus (DMT2) on glycemic control.MethodsIn this feasibility, prospective, randomized, single-blinded, multicenter study elderly patients with DMT2 capable to use the IoT telemonitoring device, with an HbA1c > 7.5 were followed-up...

ea0099ep922 | Calcium and Bone | ECE2024

Anti-osteoporosis therapy after discontinuation of menopausal hormone therapy: a systematic review

Anagnostis Panagiotis , Divaris Efstathiios , Bosdou Julia , Tournis Symeon , Stathopoulos Konstantinos , Goulis Dimitrios

Objective: Menopausal hormone therapy (MHT) is efficacious in reducing the risk of vertebral, non-vertebral and hip fractures, irrespective of age, falls risk or baseline FRAX probability. However, the optimal sequential anti-osteoporotic treatment after MHT discontinuation has not yet been designated. This systematic review aimed to obtain the best evidence regarding the effect of antiresorptive or osteoanabolic treatment on bone mineral density (BMD) and/or fracture risk fol...

ea0099ep499 | Diabetes, Obesity, Metabolism and Nutrition | ECE2024

Impact of the world diabetes day in greece

Ragia Dimitra , Dionysopoulou Sofia , Kouroglou Eleni , Belis Konstantinos , Proikaki Stella , Ilias Ioannis

Introduction/Aim: In this study, we aimed to evaluate the long-term impact of the diabetes awareness day in Greece (in 2016-2023), which is organized every year in November, by examining the relevant local internet searches.Materials/Methods: We collected monthly data with Google Trends, exclusively from Greece, on relevant [online] search volumes (RSVs), with keywords "diabetes" (study group; in medical/scientific and lay terms, in Greek and in ...

ea0067o67 | Oral Presentations | EYES2019

Treatment intensification with novel antidiabetic agents alters platelet function parameters in patients with type 2 diabetes

Bletsa Evanthia , Siasos Gerasimos , Stampouloglou Panagiota K , Paschou Stavroula A , Antonopoulos Alexios , Batzias Konstantinos , Gouliopoulos Nikolaos , Zaromytidou Marina , Oikonomou Evangelos , Tsigkou Vasiliki , Mourouzis Konstantinos , Pavlou Efthimia , Kozanitou Maria , Thanopoulou Anastasia , Vryonidou Andromachi , Kassi Eva , Tentolouris Nikolaos , Pallantza Zoi , Tousoulis Dimitris

Background: Patients with type 2 diabetes (T2D) are at higher risk for thrombotic events and as a result cardiovascular disease. Platelet function may be used to assess prothrombotic state in patients with cardiovascular disease.Purpose: We aimed to investigate whether the administration of novel antidiabetic agents influence platelet function in TDM2 patients.Patients and Methods: We 60 enrolled consecutive patients with T2DM, on ...